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Since cellular retinol- and retinoic acid-binding proteins 
(CRBP and C RABP) mediate the effects of vitamin A on 
epidermal differentiation , the levels o f these binding pro-
tems were measured in the epidermal and dermal layers o f 
neWborn, human fo reskin as well as in primary cultures 
of keratin ocytes and fibro blasts from these layers. Ligand 
b[3iJlding assays with sa turating con centrations of all tra /1S-
H]retlllol or o f all tralls-[11-3H]retinoi c acid were used to 
quantitate amounts o f binding proteins in cytosols prepared 
from these skin layers o r cultured cell s. The epiderm al 
eveIs of C RABP and C RBP (60.9 ± 14.4 and 7.3 ± 1.7 
pmol per m g cytosol protein, respectively) were markedly 
higher than that reported for adult epidermis but w ere 
co mparable to levels in keratinocytes cultured from neo-
natal foreskin epidermis (61.8 ± 7.8 and 10.7 ± 2. 5, re-
spectively) . The levels o f C RABP w ere much lower in the 
foreskin dermis th an in the epidermis and the levels m ea-
sured in the fibrobla sts cultured from this dermis w ere 
consistent with the dermal levels. H owever, C RBP levels 
in cultured dermal fibrobla sts were very low and could not 
account for the dermal C RBP levels, sugges ting that an-
other dermal cell type has high levels of C RBP. J !rlllesl 
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V itamin A is required for no rmal epithelial differen-ti ati on and g row th [1 ,21. T his vitalTlin acts directl y on keratinocytes since it prevents these cells in pure culture fro m terminall y differenti atin g and fo rmin g . th e co rnifi ed envel ope [3]. At th e m olecular level, 
~Ita ll1in A promotes the expression of the lower-m olecular-weight 
era tll1S w hile inhibiting th e ex pression o f the higher-m olecular-
WeIght keratins [3]. Although this direct effect on keratin expres-
SIOn agrees w ith th e hypo th esis [4] that vitamin A contro ls ge-
llomIC expression in a stero id horm one-like manner, th e exact 
1l1echanism o f vitamin A action is no t know n. It is known, how-
ever, that 2 sepa ra te vitamin A-bindin g proteins are found in the 
~~ to pl asm of m any cell s [4- 6], one fo r retino l (CRB P) and one 
I r ret1l1 0IC aCId (CRABP). T wo maj o r hn es o f eVIdence suggest 
~1 a t the bio logic effects o f vitamin A are mediated by these 2 
bIndIng proteins. First, those vitamin A analogs that have high 
lologic ac tivity bind ti ghtl y to one o r o th er o f these binding 
proteins [7,8]. Second , tiss ues in which vitamin A transpo rt is 
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C RAEP: ce llular rctino ic acid- binding pro tein 
e RE P: ce llular retino l-binding pro tein 
FES: fetal bovine se rum 
M EM : mini ma l essential m edia 
PES: D ulbecco's phos phate-bu ffered sa line (ca lcium- and 
nlagncs i um-free) 
essenti al (liver, kidney) o r whose fun ction is dependent on vitamin 
A (tes tes, epididymis) ha ve high levels o f these binding pro teins 
[9, 10]. 
Because vitamin A is necessa ry for no rm al keratin ocyte dif-
ferenti ation, high levels o f its cellular binding pro teins would be 
expected in skin in general and epidermis in parti cular, but high 
levels have no t been consistentl y fo und [9-1 41. While differences 
in binding pro tein assays m ay account fo r so m e of these di screp-
ancies 1'1 0], the diffi culty in co mpletely ho mogenizin g mam m al-
ian skin is more likely to be a major so urce o f the discrepancies . 
Because cultured cells are readily homogenized , C RB P and C RA BP 
levels in primary cul tures o fk eratin ocytes o r fibroblasts m ay give 
an accurate indicati on of epiderm al o r derm al levels if these cells 
are the sole so urce of these bindin g pro teins in the tissues . T he 
levels o f cyto plas mic vita min A-bindin g pro teins in epidermis 
and in keratin ocytes cultured from that epidermis have no t been 
directl y compared , no r have derm al and fibroblas t levels been 
directl y compared. We repo rt , here, just such a compari son of 
th e levels of C RABP and C RBP in the epiderm al and derm al 
layers o f human neonatal fo reskin w ith the levels in cultu red 
kera tinocy tes and fibroblas ts obtained from these la yers. 
MATE RIALS AND METHO DS 
Eagle 's minim al essenti al m edia (M E M) w ith Hanks' balanced 
salt solution and 25 mM HEPE S buffer , pH 7.2, w as obtained 
from G rand Island Bio logical Company, and M C DB 153 m edia 
cam e fro m K C Bio logicals and fetal bovine serum (FBS) fro m 
Hyclone Tissue C ulture Products. Worthin g ton T ype III coll a-
genase was purchased from C ooper Biomedi ca l, In c. Boehringer 
Mannheim Biochemi ca ls provided dispase II. Unbbeled all-tralls-
retino l, unlabeled all-trans-retino ic acid , bovine pancreas ribo-
nuclease A, chicken egg albumin, 2 x crys tallized bovine pancreas 
trypsin, disodium eth ylenediamine tetraacetic acid (EDT A) , phenyl-
m eth ylsulfonyl flu o ride, and tris(h ydroxymethyl) amin o meth ane 
(T ris) were obtained from Sigm a C hemica l Company. Spectro-
pho tom etric g rade dirri eth yl sulfoxide was supplied by Aldrich 
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C hem ica l Company, Dextran T-70 b y Pharmacia Fine C hem i-
cals, and Norit A by Fisher Scientific Company . Methanol , ace-
tonitri le, and hexa ne were al\ chromatograp hy grade from Bur-
dick and Ja ckson Laboratories, In c. [3H]Retinol at 15 C i/ mmol 
prepared as previous ly described rl51 was ki ndl y provided by Dr. 
David Ong (Vanderbi lt Univers ity). Batches of all -lral/S-[11-
3H1retinoic acid w ith specifi c ac tivities ofl.54 C i/m m o l and 2 .15 
C i/ Illmol were obtained from the Bio logical and C hemica l Pre-
vention Prog ram , Division of Ca ncer Cause and Prevention of 
the N ational Cancer In st itute. Bio-Gel P-60 (l00-200 m esh) and 
Econo-Column (0.7 X 10 cm) g lass co lumns were purchased 
from Bio-lbd Laboratories. The Econo-Colulllns were shortened 
to 9 cm by cuttin g off their bed support-efflu x tips. These were 
replaced with the fast-flow cellulose bed support-efflu x tips cut 
from columns supplied by Whale Scientific, Inc., Com merce C ity, 
Colo rado (cata log no. CC- 09) . 
Separation of Epidennis and Dermis Fo ll owing circum ci-
sion, normal hum an neo nata l foreskins were stored at 4°C over-
night in M E M suppl emented as described previously 1161 and 
m ade 5% in FBS . The foreskins were th en rin sed 2 X in fresh 
sterile MEM , treated for 20 h at 4°C w ith 1 unit (2 m g) of dispase 
II per ml of ME M acco rdin g to Kitano and o,kada r17]. Following 
3 rin ses in ca lcium- and mag nesium-free phosphate-buffered sa-
line (PBS) at O°C that was J mM in pheny lm ethyl su lfonyl fluoride 
and 0. 12 mM in EDTA, the sepa rated epidermis and dermis were 
centrifu ged, weighed after removing excess liquid , and sto red 
frozen at - 70°C. 
Keratinocyte and Fibroblast Cultures Keratinocytes and fi -
broblasts were o btained for ce ll culture by treating the foreskins 
w ith 0.25% trypsin in M E M for 20 h at 4°C. Keratinocytes were 
prepared for culture by in cubatin g trypsin-separated epidermis in 
M CDB 153 medium at 37°C for 20 min followed by trituration 
with a pipet. Kerat inocy tes were cultured using a method similar 
to th at ofYuspa et al [1 8]. After 10-14 days, when the keratino-
cytes had become conflu ent, they were removed with 0.1 % tryp-
sin , 0. 12 mM EDT A in PBS, then diluted with MEM plus 10% 
FBS, and collected by centrifu gation. The cell s were washed once 
by resuspension in MEM plus 10% FBS and 3 X by resuspension 
in PBS th at was 1 mM in pheny lmethylsulfonyl fluor ide and 0 .12 
mM in EDT A. The final cell pellet was weighed and stored at 
-70°C. 
Iso lated fibrob lasts were prepared for cu lture by min cing the 
trypsin-separated derm is and in cubatin g it in MEM plus 10% 
FBS and 0.2% coll agenase at 37°C for 16 h. The fibrob lasts were 
g rown and harves ted in a manner similar to the keratinocytes. 
Preparation ofCytosols Three milliliters of 0.05 M Tris- HCl 
(pH 7.5 at 22°C) and 6 ml of H 20 were ad ded for each g ram of 
ce ll or tissue sample. followed by homogenization at O°C usin g 
an U ltra-Turrax ho mogenizer (Tekmar Company). The ho m og-
enates were filtered through ga uze and l-ml aliquots removed for 
DN A determination accordin g to Burton [1 9]. The hOl11ogenates 
were processed to obtain cytosols as described by Ong and C hytil 
r201. The cytosols were frozen, lyo phili zed to dryness, and re-
constituted with 2.16 ml of H 20 per g ram o f initial sample weight. 
Following the removal of aliquots (10 /L I) for pro tein determi-
nation accord in g to Bradford [21], 0.27 ml of 20 mg/ml oval-
bumin and 0.27 ml of 20 mg/ml ribonuclease were added . The 
reconstituted cytosol was stored frozen at - 70°C until assayed 
for CRABP and CRBP. 
Binding Protein Assays The ligand bindin g assay for quan-
titating the amount of C RBP and C RABP in the tissue cy tosols 
was similar to the method previously described [221. Both 
r3Hlretinol and [3H]retinoic acid were purified by high-
performance liquid chromatography within 2 da ys of usc in the 
assay exactly as described previous ly [23) . After purification the 
specific activity of[3HJretinol was always red uced to 3.0 C i/mmol 
by adding unlabeled retinol. When nonspecific binding was de-
termined a 50-fold excess of appropriate un labeled li ga nd was 
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added. The binding mi xture was analyzed on sma ll (3.4 m l) mo-
lecu lar-sieving co lumns as previously described [22]. This co lUl111l 
procedure was modified by usin g a longer glass column and by 
pack in g and elutin g th e colullln at unit g rav ity rather than by 
centrifu ga ti o n . The co lullln s were eluted and fractio nated by re-
petitively (12 times) addin g 250-/Ll ali qu o ts of 0.05 M Tris-HCl , 
pH 7.4 at room tem perature, at 4-m in intervals. Fractions were 
coll ected every 4 min coin cident w ith the additi o n of elu ent. Thc 
amount of tritiated li gand in each of the last 10 column fra cti ons 
was calculated from the amo unt of tritiulll determined by liquid 
scintillation co unting. Specific binding was determined and used 
to calculate the amount ofCRBP or CRAB P per amount of ti sS Ll c 
as described prev io usly r23]. T he signifi can ce of the difference 
found between 2 different types of samples was eva luated usin g 
a Student's I-tes t. A paired I-tes t was used w here sa mples could 
be paired and eq ua l va rian ces were always assum ed unless thc 
number of va lues in th e 2 g ro ups being co mpared was not iden-
tical. 
RESULTS 
Dispase II treatment has been reported ['17] to cleanly separatC 
dermal and epidermal layers w hil e preserv ing the architectural 
details of the ep idermis. By hi sto logic exa minatio n, we did not 
detect cross- contamination of th e sepa rated epidermal and derl11 Jl 
layers (data not shown). Furthermore we found that keratinocytCS 
cultured after trypsinizing th e dispasc-se parated ep id ermis o nly 
occasionally had sma ll areas of fibroblast contamination. 
To minimize the potential degradation of CRB P and Cn. ABP 
during the preparation of cytosols by res idual dispasc, skin sa m-
ples were w ashed severa l times with a buffer con tainin g EDT A, 
a known [1 7] inhibitor ofd ispase. To eva luate th e loss ofb indill g 
protein due to dispase proteo lys is. foreskins were cut into halveS 
long itud inall y along the midlin e and o ne half was treated with 
dispasc w hil e the other half was treated id <; nticall y w ith out dis-
pase. Both halves were washed and processed to o btai n cytosol 
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Figure 1. Liga nd binding assays for CH. ABP and for C H.SP in control 
and dispase-trcarcd hum an neonatal foreskins . Cytosols (ISO fLI ) fronl 
control (A,C) and from dispase-treatcd (B,D) foreskins were in cubated 
with all-tmlls-1'11-J H]retinoic acid (A,B) or with all-tmlls-[3H]retinol in a 
tota l volume of 200 fLl and fractionated on a small molccular-sievin~ 
column as described in Ma terials atld Melhods. Cytosols were reconstitu te( 
to givc 3 ml per g of pretreatment weight of identical fores kin hal veS. 
Control sa mples were treated identically to the dispase-trcated sa mples 
except dispase was omitted. For each of the skin sa mples. specifiC bindi1l~ 
was com puted as the differcnce between tota l (-e-) radioactivity bOll 1l 
minus rad ioacti vity nonspccifica ll y (- 0 -) bound in fractions 3 through 
6 or 7. 
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Table I. C RABt' and C RB!:' Levels in Untrea ted and 
Dispase-Treated Human Neo natal Fo reskin 
------------------------------------------------------
C l'tAJ3P C I<I3 I'. Prote in DN A 
(p lllo l/g (p lllo l/g (mg/g (n lg/g 
wet wt) wet w t) wetwt) wet wt) 
Untreated 8 1. 6 ± 1').7 \1.0 ± 2.2 7.2 ± 1.6 0.42 ± 0. 12 ~ase-trca ted 168.3 ± 72.\1 17.0 ± ').4 10.7 ± 1.3 0.56 ± 0. 14 
Without atte mptin g to se parate the dermis and epidermis and the 
cytosols we re anal yzed for C RBP and C RABt> . The resul ts of 
~;l C such ex perim ent arc : hown in Fig 1. The pea k of specifi c 
bi:ldlng, w hi ch IS th e dlfteren ce between total and no nspec ifi c 
ldl ng , IS clea rl y seen m fra ctIo ll 4, w hi ch correspond s to where 
CRBP and C RABt' clute. The dispase-treated sa mples (Fi g 18, 
D) have nearl y tw ice as mu ch specifi c bindi ng, and therefore 
;lR~B~ or C nBP, as the contro l sa mples (Fig l A,C). Since 
beese,1 es ults arc. based o n th e wet we igh t of Identi ca l sa mples 
fO le trea tm g With dlspase, tl1lS trea tment docs no t destroy c nBP 
Or C RABP but in stead increases their m easured levels. 
To understand w hy dispase treatm ent in creased the level of 
cytop las mic vitamin A-b inding proteins, ho m ogenate D NA and 
~ytoso li c protein va lues were also determ ined o n unt reated and 
Ispase-trea ted contral3teral fo reskin halves. Table I shows th e 
llican and standard deviat ion of th ese determinations and ofCRABP fnd C I~n p levels in 5 separate sample pairs. C RBP and C RABP 
e~ds In creased an ave rage of2-fo ld following dispase treatm ent, 
~v 111e the cy toso li c pro tein and ho m ogenate DN A lev els increased 
y 3/2 and 4/3, res pecti vel y. Considered alo ng With the o bser-
Vat ion that dispase treatment ca used the skin to swell , these in-
creases strong ly sugges t that proteo lysis by di spase deg rades the 
Intracellular matri x m akin g the skin easier to ho mogenize and 
reSultin g in better recovery of cy toso li c co mponents. 
I The m ea n and standard devi ation of the C RBP and C RABP 
eVels determi ned fo r 5 batches of dispase- se parated epidermis 
and d,. · I . T bl C fo ld ell1llS are s 10wn In a e II. ~ABP .'evels arc about 9-
hi gher than C RBP levels III the epidermiS w hil e both levels 
a rei mu ch lower in th e dermis and arc nearly identica l to each 
at ler A . h' I ' s seen m Table I C RABP levels arc also 9- to 10-fo ld 
s~~;cr t!un C RBP levels in . either un treated o r dispase-trea ted 
I . Because the rati o of bmdll1g protem level s IS Identi ca l 111 
~v 10le skin and epidermis but not in dermis , th e m aj ority of the 
IndlI1g pro teins must be in the epidermis. Based on th e wet 
~elght o f se parated epidermis and dermis (weight increase due 
dO Swelling = 31. 0 ± 6.5%), on ly 10.4% of the skin was epi-
erl1lIS and yet 88% o f C RABP and 56% of C RBP were in the 
epiderm is. 
To determine w heth er the amoun t of C RABP and C RBP in 
epld
l 
crmis and dermis co uld be attributed to the m ain ce ll type o f 
eaCl sk ' I . s In ayer, cultured keratll10cy tes and fibro blasts were as-
t ayed for the vitamin A-bindin g pro tein s. O nl y keratin ocy te cul-
LIrcs w' I d b l fib . . tl It lOut crecta e I roblast contamll1 atIon were used for 
s lese assays. Table III shows the mean and standard deviation fo r 
~Pla ra te batches of keratin ocytes (n = 4) and fibroblasts (n = 5). 
LI tured k ' I' k d ' d 'd . I . I eratIn ocy tes I ' e Ispase- separate epl ermls l ave hi gh 
eve\s fC R . . 11 ' 0 . ABP and also have CRBP. While CLlltured fibro blasts 
.IVe a . bl (I . pprecla e levels of CRABP, C RBP levels are very low 
able III ). A compari son of the binding pro tein levels in isolated 
Table II. C RABP and C nBP Levels in Epide rmis and 
D ermi s of Human N eonata l Fores kin 
---------------------------------------------
C RJ3P Protein / DNA C HABP 
(p mol/ l11 g protein) ______ (pmol/ mg pro tein) (mg/ mg) 
Epid crlll-i s---------------------------------------=-----=~-
Derlllis 60.9 ± 14.4 7.3 ± 1. 7 11. 7 ± 1.2 
____ . 2.4 ± 1. 9 1.7 ± 0.6 35.6 ± 10.8 
---------------------------------------
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Table III . C RABP and C n.BP Levels in Keratinocytes and 
Fibrob lasts C ultured fr o m Human N eonata l Foreskin 
C RAllP C RJ3!' 
(p ll1 o l/ ll1g prote in) (pll1ol/m g pro tein) 
!'rotein/ DN A 
(111 g/ lll g) 
Kcrat inocytcs 
Fibroblasts 
6 1.8 ± 7.8 
9.2 ± 2.0 
10.7 ± 2.5 
O.h ± 0.2 
21.3 ± 2.7 
16.4 ± 3. 1 
kcratinocy tes and fibroblas ts w ith epiderm al o r derma l levels is 
shown in Table IV . In kerat inocy tes each bindin g protein le vel 
is the sa m e as or hi g her than its co rrespondin g bindin g protein 
level in epiderm is w hether ex pressed per m g pro tein o r per m g 
D NA . Apparently keratin ocytes ca n accoun t fo r virtuall y all of 
the vitami n A-bindin g proteins found in ep idermis. While fibro-
bl as ts have the sa me or hig her levels of C RABP than the dermis 
does , C RBP levels are significantl y lower in fibrob lasts th an in 
dermis w hether based o n protein or DNA . T herefore, fibroblasts 
can accolln t fo r the C RABP le vels in dermi s, but they ca nn o t 
acco llnt for the derma l C RBP levels. 
A uniqu e vita min A-bindin g protein that binds bo th retino l 
and retin o ic acid has been repo rted [24] and has been detected in 
human skin [25 ]. Beca use epidermis contain s th e maj o rity of th e 
vitamin A-bindin g pro teins, we looked for this unique bindin g 
protein in human foreskin epidermis. Sin ce this uniqu e binding 
protein binds bo th retinol and rctinoi c acid , unlabeled ret inoic 
acid competes with the bindin g of labeled retin o l to this protein 
124]. Fi gure 2 shows the resu lts of this kind of competitio n ex-
periment o n cytosol fro m iso lated epidermis. T he solid circles in 
the upper panels show th e bind ing of 13 Hlretin o ic acid in the 
absence (A) and presence (8) of excess unlabeled retinol. Simil arl y 
the solid circl es in the lower panels show th e binding of l3H]retinol 
in the absence (C) and pn:sence (D) o f excess unlabeled retin o ic 
acid . C learl y, no signi fica nt co mpetitio n ca n be detected. Labeled 
li ga nd is readi ly displaced by an excess of the same unl abeled 
li ga nd as shown by the open circles. T herefore, the ep ide rmis of 
human neo natal fo reskin does not appear to 11Jve a uniqu e vitamin 
A-bindin g pro tein that binds both retin o l and retinoic acid. A 
similar conclu sion appli es to th e dermis, since the majority of the 
specifi c binding of 13l-l]retino l in derm al cy tosol could no t be 
displaced by excess cold retino ic acid (data .not shown). 
D ISC USSION 
In this stud y very high C RABP levels and mu ch lower C RBP 
levels were found both in hum an epidermis and in cultured ke-
ratinocy tes. H owever, both the levels of C RABP and C RBP are 
always lower in epidermis than in cultured kerat inocytes when 
levels are expressed per m g DNA. T his probab ly reflects the 
difficulty in co mpletel y ho m ogenizin g the epidermis and re-
covering the cy tosoli c binding proteins as compared to the nea rl y 
tota l recovery of bindin g protein s from the easily homogenized 
cultured keratin ocy tes. T his comparison of retin oid-binding pro-
tein levels in cy tosols fro m epidermis and cultured keratinocytes 
is also co mpli ca ted by th e potentia l differences between in si tu 
Table IV. CO ITlpar ison of Vitamin A-Binding Pro tein Levels 
in Kera tinocytes to Epiderma l Levels and in Fib roblasts to 
Derma l Levels 
C RAJ3!' per m g of: 
lta tio of kcrat inocy tc 
to epidermal k vcls 
Ibtio of fibroblast to 
derma l levels 
Cytosol 
Protein 
1. 0 
(N S)" 
3.8 
(1' < 0 .00 1) 
''Not s ig ni ficant s in ce p > 0.05. 
DNA 
1.9 
(p < 0.02) 
1. 5 
(NS) 
C RJ3P per mg of: 
Cy tosol 
Protein 
1. 5 
(N S) 
0.4 
(I' < 0.01) 
DNA 
2.6 
(I' < 0.0 1) 
0.2 
(I' < 0.01) 
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Figure 2. Competition by unlabeled ret ino l in the C RABP assay and by 
unlabe led retinoic acid in the CRBP assay. Epiderma l cytosol (20 ILl ) was 
incubated w ith all-tral!S-[11-3H]retino ic acid in the presence (8) or absence 
(A) of 50 ILM unlabeled retinol to determine tota l bindin g (-e-) ofretino ic 
acid. Epidermal cy tosol (150 ILl ) was incubated w ith all-trmls-[3H]retinol 
in the presence (D) or absence (C) of 50 ILM un labe led retinoic acid to 
determ in e to tal binding (-e-) of retinol. The in cubation, fractionation , 
and subsequent ca lculation were done as described in the legend to Fig 
1. The no nspecific binding (-0 -) in A and B was determined using 50 
ILM un labeled ret in oic acid in the absence of unlabeled retinol whi le the 
nonspecifi c bindin g (-0 -) in C and 0 was determined usin g 50 ILM 
unlabeled reti nol in the absence of unlabeled retin oic acid. 
and cultured keratil;ocytes. Given th ese experimental li mitations, 
the m aj o r cell type in human epidermis, the keratinocyte, appears 
to contain almost all of the epidermal cellul ar vitamin A-binding 
proteins. 
The C RABP level in hum an neonatal foreskin epidermis of 6] 
pmollm g protein detected in th is study is considerably higher 
than previously reported levels for norm al adu lt hum an epidermis 
(3.7-26.5 pmollmg protein) [1 ]-14,26]. While this difference could 
suggest that the level of epiderm al CRABP decreases w ith age, 
we found that keratinocytes cultured fro m newborns o r from 
youn g adults have comparable levels of both C RABP and C RBP 
(R. E. Ga tes and L. E. Allred , unpublished observations) . Others 
(27) found C RABP levels in newborn keratinocy tes much lower 
th an we detected .in newborn keratinocytes (13.5 vs 62 pmollmg 
protein). Therefore, the higher levels of CRABP found here are 
probably not due to age differences. The hi gher levels are more 
likel y due to the hi gher values m eas ured in our improved ligand 
binding assay [22) and , as noted in the R esults, to the nearl y 2-
fold increase in recovery of the bi ndin g proteins in homogenates 
of dispase-treated skin. 
When dermiS is digested with coll agenase to obtain fibro blas ts 
for culturin g, fra gm ents of microvessels contain ing eryth rocytes 
are seen microscopica ll y (data not shown) . Since these erythro-
cytes contain soluble protein but no DNA , they may account for 
th e hi gh protein to D N A ratio in the dermis w hi ch results in 
artificiaUy low levels fo r CRABP and CRBP in the dermis w hen 
expressed per m g protein. T he possible presence of serum retinol-
binding protein in the microvessels could contribute sign ificantl y 
to the retin ol binding measured in the dermis. Although the small 
amount o f retinol binding in the dermis is diffi cult to qu antitate, 
the majority of the retinol binding in the dermal cytosol was not 
abolished by excess retino ic acid . Since excess retinoic acid does 
compete for and abolish th e binding of labeled retinol to serum 
retinol-bindin g protein [28], the maj ority of the dermal retinol 
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binding must be due to C RBP and not to serum retino l-binding 
pro tein . 
In the fibrob las t, levels of C RABP were hi gher and levels of 
C RBP were lower than in the dermis whether ex pressed per Il1g 
pro t,ein or per mg D NA . Therefore, fibrob las ts as th e major 
dermal cell type can acco un t for all of the derma l C RABP, but 
ca nn ot account for m ost of the derma l C RBP . One ex planation 
for the hi gher derma l levels of C RBP would be m arked differ-
ences in th e expression o f the binding pro teins betw een in situ 
and cultured fib rob las ts. With this ex planation, as seen in Table 
IV , CRABP levels would increase significantl y w hen fibroblastS 
are cul tured w hil e C RBP levels would decrease signifi ca ntl y. An-
other, perhaps more probable, ex planation is that so me cell type 
in th e dermis other than the fibroblas t, such as the endothelial 
cell , contains hi gh levels of C RBP . 
We tl/allk Dr. Lloyd Killg Jor help.!i" disCll ssioll s alld 5l1ggesriollS. We (/(kll ollll-
e~~e th e expert tcc/mica l ass istallce oj Ms. Rebecca Cariglietli alld IIJ Ms. Jlldit li 
S II'a ll soll . 
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